Dr. Yamauchi is a dermatologist in private practice and is the medical director of the Dermatology Institute and Skin Care Center of Santa Monica, and is affiliated with St. Johnís Hospital in Santa Monica and the Encino/Tarzana Hospital in Encino, CA. Dr. Yamauchi is on clinical faculty in the Division of Dermatology at the David Geffen School of Medicine at UCLA. He specializes in cosmetic dermatology, laser and surgical procedures, medical dermatology, and clinical research.

Dr. Yamauchi earned his BS in biochemistry at the University of California at Los Angeles, his PhD in biologic chemistry at the University of California at Santa Barbara, and his MD at Case Western Reserve University School of Medicine in Cleveland. He completed his residency in dermatology at UCLA School of Medicine and a cosmetic surgery fellowship affiliated with UCLA School of Medicine.

Dr. Yamauchi is a fellow with the American Academy of Dermatology, the American Academy of Cosmetic Surgery, the American Society of Dermatologic Surgery, the American Society for Laser Medicine and Surgery, and the Pacific Dermatology Association. He is also a member of the Los Angeles Metropolitan Dermatologic Society. He serves on the editorial board of the Journal of Cosmetic and Laser Therapy. He is the author or co-author of numerous publications, including three books.

Dr. Yamauchi has given several television media interviews locally in Los Angeles as well as nationally on ESPN and internet webcasts. In addition, he has been quoted several times in the Los Angeles Times, Los Angeles Daily News, Dermatology Times, and Skin and Allergy News. He has been voted one of America’s Top Physicians in Dermatology and Cosmetic Dermatology and elected in Marquis Who’s Who in America and Who’s Who in Medicine and Healthcare.

Dr. Yamauchi has spoken at several national and regional meetings on cosmetic dermatology. He has lectured extensively on new advances in soft tissue fillers such as Evolence®, Restylane®, Hylaform®, Sculptra®, and fat transfer. He has given several talks on new indications for Botox. In addition, he has spoken on advances in laser treatment such as laser hair removal and combination therapy using ablative laser with Botox. Dr. Yamauchi has written several articles on the use of Botox for rejuvenation and other indications as well as advances in laser treatment such as the Rytec laser. He has conducted several clinical trials on Botox, new advancements in filler agents, and innovative lasers for rejuvenation and skin tightening.

Dr. Yamauchi conducts numerous clinical research trials at Clinical Research Specialists in Santa Monica. He serves as a principle investigator in several studies including new therapies for psoriasis, skin cancer, eczema and acne.

Dr. Yamauchi is recognized as a key opinion leader in psoriasis and has extensive experience using the new biologics in the treatment of psoriasis, and has been invited as a speaker at national, regional, and local venues to talk about new advances in the treatment of psoriasis. In addition, he is a strong advocate in establishing patient support groups for psoriasis. Dr. Yamauchi has published extensively in new advances in the treatment of psoriasis.

Dr. Yamauchi has also spoken on other dermatologic conditions at national and local meetings and has published articles on acne, eczema, skin conditions associated with rheumotologic conditions, and hyperhidrosis.


SELECTED PUBLICATIONS AND PRESENTATIONS:

BOTOX
P.S. Yamauchi, Lask G, Lowe N. Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing.J Cosmet Laser Ther. 2004 Sep;6(3):145-8.

P.S. Yamauchi, Lowe NJ. Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis. Clin Dermatol. 2004 Jan-Feb;22(1):34-9.

Lowe NJ, P.S. Yamauchi. Cosmetic uses of botulinum toxins for lower aspects of the face and neck. Clin Dermatol. 2004 Jan-Feb;22(1):18-22.

Lowe NJ, P.S. Yamauchi, Lask GP, Patnaik R, Iyer S. Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg. 2002 Sep;28(9):822-7.

Lowe NJ, Lask G, P.S. Yamauchi , Moore D. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. J Am Acad Dermatol. 2002 Dec;47(6):834-40.

N.J. Lowe, P.S. Yamauchi, G.P. Lask, R. Patnaik, and D. Moore. Botulinum Toxins Types A and B for Brow Furrows: Preliminary Experiences with Type B Toxin Dosing. Journal of Cosmetic and Laser Therapy. 4, 15-18. (2002)

LASERS
van Vliet M, Ortiz A, Avram MM, P.S. Yamauchi. An assessment of traditional and novel therapies for cellulite. J Cosmet Laser Ther. 2005 Mar;7(1):7-10.

Tournas JA, Lowe NJ, P.S. Yamauchi. Laser and novel light source treatments for psoriasis. Lasers Surg Med. 2004 Sep 22

Kormeili T, P.S. Yamauchi, Lowe NJ. Topical photodynamic therapy in clinical dermatology. Br J Dermatolo. 2004; 150: 1061-9

Rohrer TE, Chatrath V, P.S. Yamauchi, Lask G. Can patients treat themselves with a small novel light based hair removal system? Lasers Surg Med. 2003;33(1):25-9.

Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, Lucky AW, Pariser RJ, P.S. Yamauchi. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol. 2003 Feb;48(2):227-32.

P.S. Yamauchi, T.T. Soriano, and G.P. Lask. Treatment of Port-wine Stains Using the Pulsed-Dye Laser at 585 nm with the Dynamic Cooling Device. Journal of Cutaneous Laser Therapy. 2, 33-36. (2000).

P.S. Yamauchi, A.P. Kelly, and G. P. Lask. Treatment of Port-wine Stains Using the Pulsed-Dye Laser at 585 nm with the Dynamic Cooling Device. Treatment of Pseudofolliculitis Barbae with the Diode Laser. Journal of Cutaneous Laser Therapy, 2, 109-111 (1999).

FILLER AGENTS
Autologous Fat Transfer for Soft Tissue Augmentation. Superficial Anatomy and Cutaneous Surgery. San Diego, CA.

Practical Considerations on Filler Agents for Soft Tissue Augmentation. UC Irvine Grand Rounds. Irvine, CA.

Sculptra and Fat Transfer for Soft Tissue Augmentation. American Society for Dermatologic Surgery Filler Course. Beverly Hills, CA

Sculptra and Hylaform for Soft Tissue Augmentation. California Society of Plastic Surgeons Meeting. Paradise Point Resort and Spa. San Diego, CA

Current and Emerging Fillers for Soft Tissue Augmentation. 12th Annual International Laser Cosmetic Surgery Meeting. San Diego, CA

MEDICAL DERMATOLOGY
Thiboutot DM, Shalita AR, P.S. Yamauchi, Dawson C, Arsonnaud S, Kang S; on behalf of the Differin Study Group. Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study. Skinmed. 2005 May-Jun;4(3):138-46.

P.S. Yamauchi, Gindi V, Lowe NJ. The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety. Dermatol Clin. 2004 Oct;22(4):449-59.

Kormeili T, Lowe NJ, P.S. Yamauchi. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences. Br J Dermatol. 2004 Jul;151(1):3-15.

P.S. Yamauchi, D. Rizk, T. Kormeili, R. Patnaik, and N. Lowe. Systemic Therapies for Psoriasis Ė Where are We Now. J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S66-77.

P.S. Yamauchi, N.Q. Nguyen, and P.E. Grimes. Idiopathic CD4+ T Lymphocytopenia Associated with Vitiligo. Journal of the American Academy of Dermatology. 46, 779-782. (2002).

 
     
 
Our Practice | Dr. Paul Yamauchi | Clinical Science Institute | Contact Us | Maps | Terms of Use
Our Services: Cosmetic Dermatology | Laser and Surgical Procedures | Medical Dermatology
MedNet-Sites by MedNet Technologies

MedNet-Sites™ - Powered by MedNet Technologies, Inc.